meta
|
evidence
oncology
Living systematic review and meta-analysis
metastatic/advanced - colorectal cancer (mCRC)
mCRC - (neo)adjuvant (NA)
mCRC - 1st line (L1)
2
mCRC - 2nd line (L2)
3
endometrial cancer
10
chemotherapy
platinum-based chemotherapy
platinum derivate
platinum association
platin and fluoropyrimidine
FOLFOX (5FU/leucovorin/oxaliplatin)
immune chekpoint inhibitors
anti-PD-(L)1
atezolizumab based treatment
atezolizumab plus bevacizumab
atezolizumab plus FOLFOXIRI plus bevacizumab
nivolumab based treatment
nivolumab plus SoC
pembrolizumab based treatment
pembrolizumab alone
no study with result for this clinical condition